Dopl Technologies raises $6.3M seed from SpringTide Ventures to advance Traverse telerobotic ultrasound toward FDA 510(k) clearance

Dopl Technologies raised $6.3 million in seed funding led by SpringTide Ventures to advance its Traverse telerobotic ultrasound platform toward FDA 510(k) clearance, aiming to let sonographers remotely perform diagnostic exams in rural hospitals and reduce patient wait times. The company — founded in 2022 by a former Nvidia medical AI engineer and practicing cardiologists/radiologists — will use the funds for verification, validation, FDA submission, and pilot deployments while operating an interim traveling-sonographer service called CareBridge.

DDopl Technologies